Neurofeedback for Mild Cognitive Impairment
Trial Summary
What is the purpose of this trial?
The goal of this pilot study is to determine the feasibility, acceptability and potential impact of using neurofeedback interventions to manage cognitive, emotional, and behavioural symptoms in individuals with mild cognitive impairment (MCI). The main question\[s\] it aims to answer are: (1) What is the feasibility, acceptability, and appropriateness of using the Nonlinear Dynamical Neurofeedback intervention for persons living with MCI? (2) What is the feasibility, acceptability, and appropriateness of using the Low Energy Neurofeedback System (LENS) intervention for persons living with MCI? (3) What is the feasibility, acceptability, and appropriateness of using the Brain Music neurofeedback intervention for persons living with MCI? (4) What is the potential impact of five weeks of a neurofeedback intervention on cognitive, affective, and behavioural symptoms experienced by persons living with MCI? Participants will be randomly assigned to either the Nonlinear Dynamical (NLD), Low Energy Neurofeedback System (LENS), or Brain Music neurofeedback intervention groups or a control group receiving usual care.
Research Team
Marian Luctkar-Flude, PhD
Principal Investigator
Queen's University, School of Nursing
Eligibility Criteria
This trial is for individuals with Mild Cognitive Impairment (MCI). Participants should be willing to undergo neurofeedback interventions or receive usual care. Specific inclusion and exclusion criteria details are not provided.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Brain Music (Behavioural Intervention)
- Low Energy Neurofeedback System (Behavioural Intervention)
- Nonlinear Dynamical Neurofeedback (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kingston Health Sciences Centre
Lead Sponsor
Queen's University
Lead Sponsor
Providence Health & Services
Collaborator